Literature DB >> 31562717

Development of Non-alcoholic Fatty Liver Disease (NAFLD) in Young Obese Tribal Subjects of Tripura: Link between Low 25 (OH) Vitamin-D Levels and Immune Modulators.

Avik Chakraborty1, Arkadip Choudhury2, Animesh Saha3.   

Abstract

BACKGROUND: There have been many studies conducted so far on Non Alcoholic Fatty Liver Disease (NAFLD) with its many aspects including its association with 25 hydroxy Vitamin D levels and its rather complex interplay with pro-inflammatory cytokines such as Interleukin-1a (IL-1a), Interleukin-6 (IL-6) and Tumour Necrosis Factor-Alpha (TNF-α), Interleukin-17a (IL-17a) and anti-inflammatory cytokines such as Interleukin-4 (IL-4) and Interleukin-10 (IL-10). This study was designed to show the development of NAFLD in the young tribal population of Tripura and the link between 25(OH) Vitamin D and pro-inflammatory cytokines (IL-1a, IL-6, IL-17a and TNF-ɑ) and -inflammatory cytokines such as IL - 4 and IL - 10 and the development of NAFLD while at the same time throws light on the prevalence of 25(OH) Vitamin D deficiencies and the levels of pro-inflammatory cytokines in the study group.
METHODS: The study is an analytical cross-sectional study with final population of 94 cases between 18 to 40 years of age fulfilling inclusion and exclusion criteria and an equal number of subjects from same tribal community age and sex matched taken as control population.
RESULTS: There was a significant relationship between level of 25(OH) Vitamin D and fatty liver (OR: 9.46, 95% CI: 4.82 - 18.59; p < 0.001). The mean serum 25(OH) Vitamin D level in the cases was significantly higher than the controls (17.21 ng/ ml + 6.34 ng/ml vs 26.56 ng/ml + 10.63 ng/ml; p < 0.001). There was a significant difference between the mean serum levels of IL-1a (11.50 Pg/ml ± 2.75 Pg/ml vs 8.28 Pg/ml ± 2.08 Pg/ml; p < 0.001), IL-4 (0.69 Pg/ml ± 0.43 Pg/ml vs 0.84 Pg/ml ± 0.36 Pg/ml; p = 0.009), IL-6 (2.99 ± 1.11 Pg/ml vs 2.22 ± 1.08 Pg/ml; p < 0.001), IL-10 (6.50 ± 2.76 Pg/ml vs 5.23 Pg/ml ± 2.67 Pg/ml; p = 0.002), IL-17a (5.33 Pg/ml ± 2.22 Pg/ml vs 3.64 Pg/ml ± 1.99 Pg/ml; p < 0.001) and TNF-α (6.99 ± 2.81 Pg/ml vs 5.40 ± 3.08 Pg/ml; p < 0.001) of the cases and the controls Low serum 25(OH) D [OR: 0.87 (95% CI: 0.83 - 0.92), p = 0.0001], and high IL-1a [OR: 1.52 (95% CI: 1.26 - 1.84), p < 0.0001] were independently associated with the risk of NAFLD.
CONCLUSION: 25(OH) Vitamin D concentration are lower while that of IL-1a, IL-4, IL-6, IL-10, IL-17a and TNF-α are higher in subjects with fatty liver in comparison to those without. 25(OH) Vitamin D deficiency and high levels of serum IL-1a were independently associated with the risk of development of NAFLD. © Journal of the Association of Physicians of India 2011.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31562717

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  5 in total

1.  Glutathione S-transferase T1 and M1 null genotype distribution among non-alcoholic fatty liver disease patients and its association with cytokine and adipokine profiles.

Authors:  Vasyl Prysyazhnyuk; Olexander Voloshyn; Iryna Prysiazhniuk; Tetiana Ilashchuk; Larysa Sydorchuk; Petro Prysyazhnyuk
Journal:  Clin Exp Hepatol       Date:  2020-05-27

2.  The effect of vitamin D supplementation on the progression of fibrosis in patients with chronic liver disease: A protocol for a systematic review and meta-analysis.

Authors:  Tiantian Chen; Xiaohong Zuo; Shengju Wang; Penglong Yu; Jie Yuan; Shujun Wei; Jiayi Chen; Yue Sun; Yongxiang Gao; Xueping Li
Journal:  Medicine (Baltimore)       Date:  2020-05       Impact factor: 1.889

3.  Lower levels of vitamin D are associated with SARS-CoV-2 infection and mortality in the Indian population: An observational study.

Authors:  Sunali Padhi; Subham Suvankar; Venketesh K Panda; Abhijit Pati; Aditya K Panda
Journal:  Int Immunopharmacol       Date:  2020-09-14       Impact factor: 4.932

4.  Low serum vitamin D concentrations are associated with obese but not lean NAFLD: a cross-sectional study.

Authors:  Qinqiu Wang; Xiaoying Shi; Jinghua Wang; Juanwen Zhang; Chengfu Xu
Journal:  Nutr J       Date:  2021-04-01       Impact factor: 3.271

5.  Revealing the Mechanism of Huazhi Rougan Granule in the Treatment of Nonalcoholic Fatty Liver Through Intestinal Flora Based on 16S rRNA, Metagenomic Sequencing and Network Pharmacology.

Authors:  Yingying Liu; Yingying Tan; Jiaqi Huang; Chao Wu; Xiaotian Fan; Antony Stalin; Shan Lu; Haojia Wang; Jingyuan Zhang; Fanqin Zhang; Zhishan Wu; Bing Li; Zhihong Huang; Meilin Chen; Guoliang Cheng; Yanfang Mou; Jiarui Wu
Journal:  Front Pharmacol       Date:  2022-04-26       Impact factor: 5.988

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.